Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. - Wikidata - awgldk - TriplyDB

Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity.

Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity.

http://www.wikidata.org/entity/Q35095489

about

Neuron-derived neurotrophic factor functions as a novel modulator that enhances endothelial cell function and revascularization processes Adipolin/C1qdc2/CTRP12 protein functions as an adipokine that improves glucose metabolism Herbal medicines for the treatment of nonalcoholic steatohepatitis: current scenario and future prospects Inflammation and metabolic dysfunction: links to cardiovascular diseases Sex dimorphism and depot differences in adipose tissue function Adipocytokines and obesity-linked disorders Downstream signaling pathways in mouse adipose tissues following acute in vivo administration of fibroblast growth factor 21 Metabolic Adaptation in Obesity and Type II Diabetes: Myokines, Adipokines and Hepatokines Biological functions of macrophage-derived Wnt5a, and its roles in human diseases Revisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolism Recombinant adiponectin does not lower plasma glucose in animal models of type 2 diabetes A Comprehensive Inter-Tissue Crosstalk Analysis Underlying Progression and Control of Obesity and Diabetes Adipokines in inflammation and metabolic disease Nutritional approaches for managing obesity-associated metabolic diseases.Exercise effects on perivascular adipose tissue: endocrine and paracrine determinants of vascular function.Adipocytokines in obesity and metabolic disease.Obesity, inflammation, and lung injury (OILI): the good.Childhood abuse is associated with methylation of multiple loci in adult DNA.Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.The effects of diet induced obesity on breast cancer associated pathways in mice deficient in SFRP1.WNT5A-JNK regulation of vascular insulin resistance in human obesity.Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects.Tissue factor-protease-activated receptor 2 signaling promotes diet-induced obesity and adipose inflammation.Antiangiogenic actions of vascular endothelial growth factor-A165b, an inhibitory isoform of vascular endothelial growth factor-A, in human obesity Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice.Wnt5a promotes ewing sarcoma cell migration through upregulating CXCR4 expression.Inflammation, metaflammation and immunometabolic disorders.Association of secreted frizzled-related protein 4 (SFRP4) with type 2 diabetes in patients with stable coronary artery disease An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease Adipokines as novel biomarkers and regulators of the metabolic syndrome.Selective modulation of Wnt ligands and their receptors in adipose tissue by chronic hyperadiponectinemia.Distinct role of FoxO1 in M-CSF- and GM-CSF-differentiated macrophages contributes LPS-mediated IL-10: implication in hyperglycemia.Macrophage recruitment in obese adipose tissue Comprehensive RNA-Seq expression analysis of sensory ganglia with a focus on ion channels and GPCRs in Trigeminal ganglia Mice deficient in Sfrp1 exhibit increased adiposity, dysregulated glucose metabolism, and enhanced macrophage infiltration Transcriptional regulation of an insulin-sensitizing adipokine adipolin/CTRP12 in adipocytes by Krüppel-like factor 15.Reduced adipose tissue inflammation represents an intermediate cardiometabolic phenotype in obesity.Wnt signaling regulates hepatic metabolism.Association of circulating C1q/TNF-related protein 1 levels with coronary artery disease in men.Noncanonical Wnt signaling promotes obesity-induced adipose tissue inflammation and metabolic dysfunction independent of adipose tissue expansion

P2860

Q24294242-3E63945A-3F7D-4182-A43A-3FB53855AAC2 Q24635256-28DD61A6-33AD-49AA-B4C5-8C845135E8D4 Q26828615-CDCA7BB2-3F7F-4BDF-9F86-B57277DCD6AF Q26851186-8829CAE9-B9B4-4FC9-A29D-298E0C472C22 Q26999869-C47800F4-BED1-4D7B-94B9-B49A3FBAC785 Q27021977-BBE0C720-88CB-442E-9E32-7D6B9275E9F2 Q27308344-CE0D37D6-9B9C-4DDB-9EDC-C97D755191F5 Q28066564-209DB3EA-D513-4205-BE38-AEFEB23E8FA5 Q28079931-9CB30537-D204-45CD-BA98-19BFA6520260 Q28085224-B72367E9-6890-4247-BCBB-C0E786C1AF57 Q28484170-ABF27109-9818-499A-805C-644B1FDCD141 Q28646647-7B5F1580-0CDB-465F-AE7E-4DE2296CDF7E Q29620456-FFBFC70C-D98B-4C7B-8B3B-82A392F25F1B Q30234850-8151C1E4-3BA0-4C3A-81FD-43DE590CD0F2 Q30238666-4D60A3BE-0156-4E1F-85D9-A6691E0B8FEE Q30357655-EF38B479-AD63-4A78-93A3-03BDE67C036E Q30363313-98514CCB-9B89-4DBE-A0CC-CB51F5F65453 Q33557021-62DE7F78-9580-4980-A04B-1FEC40F47929 Q33580624-12E1687D-4D22-476B-B31D-2EE24B11634F Q33768390-BBDDC2B6-8D0E-49D5-AFA2-570B34BA188C Q33853951-AAA14CEA-CDC3-42A9-8A28-23E2FE14A0F3 Q34182705-82E25CD6-87B4-4867-B6C0-E30F47EFDF70 Q34226558-0C0A187C-0438-4677-8E9F-DD9DBF467E76 Q34244804-931DA8CF-AE88-4183-B298-BE80434DFE9A Q34322168-E6DF0C9D-8C78-4FFB-A7AC-ACBA9683FD23 Q34449657-A26D62D9-B3D6-4136-ACFB-A8ADD918A1ED Q34550852-82343F1F-D775-4027-8454-2F0EA1385E84 Q34586921-C9EA959C-42EB-4908-B986-8736446C9C06 Q34641120-243E4C40-DAE8-4832-AA11-B9538FB242FC Q34786187-8E05F6FA-8726-4A90-A5B5-B5DC340C53C9 Q34825893-1BB24914-588C-4A69-96C4-C6DEE4F407E2 Q35005905-BE4F1532-0E82-475F-9341-C69469C816C0 Q35007836-DDDC7991-0534-4F01-AEF6-B58C0AF9BA81 Q35048508-30965525-F527-450F-92A1-99B9EAF8381B Q35067279-97EECE3E-D2BD-464D-B3AF-64D6982C6F26 Q35073031-1164B977-7B3D-42AE-A418-B59C281B9914 Q35094008-5449F5E3-4E9A-424A-89D7-4D399724068D Q35138570-190BDB3A-72FA-4113-87BC-114013AC97A9 Q35190964-4B804F9C-B70B-4C0E-ADA8-11555DCD19C4 Q35220578-7C84EDAB-FEFF-4992-BA6C-6E526B6F52A2

P2860

Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity.

http://www.wikidata.org/entity/Q35095489

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity.

@ast

Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity.

@en

type

label

Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity.

@ast

Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity.

@en

prefLabel

Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity.

@ast

Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity.

@en

P1433

Q35095489-D196ED6A-9ECD-43CC-9607-8180A744674A

P1476

Q35095489-5FF78CCA-4D84-485B-9AEB-9E6028338FED

P2093

Q35095489-0117A1D9-3F2B-4C66-9984-48638BC033C8

Q35095489-1FBA1009-5631-4B74-865A-FBF186480CAC

Q35095489-763E63AF-C5B5-494C-86AA-30F88441A8C8

Q35095489-97C45108-94BC-40DB-B87A-7B1B7E9F97EA

Q35095489-A58A7069-F762-4B25-8ED1-7581F25FC2D2

Q35095489-AFC75BF8-2CE3-4509-8A54-49CAAA78134A

Q35095489-F08EEDE2-F267-4134-A6CE-E577EF2FFD7F

P2860

Q35095489-0D5F67C7-DF60-4DB8-8374-42A304CA350E

Q35095489-1660EC22-58A9-4676-B090-66246EEFE007

Q35095489-24246AE7-E3E9-469F-8FB8-D1A43BDD469A

Q35095489-2DA6B2B6-82A7-4966-A575-F95E2D8ABF12

Q35095489-40CFD0E7-A4BD-4796-9427-9E7E321656DE

Q35095489-47EAF253-FBFE-4045-A786-67C8F221BB41

Q35095489-4C8F0C49-3C2F-46BB-8B35-4D478C3D4EFC

Q35095489-4D0301B0-8EAA-490E-BEDE-B5E99E1AB120

Q35095489-4D34904F-DD1E-44DE-8EA1-09B58AF90AFE

Q35095489-70AA0BA4-33BC-47A9-81DF-42182118488F

P304

Q35095489-26E901E9-75C2-480B-B7AC-04C4E905020B

P31

Q35095489-1089081B-F7F5-4B35-B193-6075FCF4740F

P356

Q35095489-2AD078DB-24BA-40AB-B80D-F3CEC3A87C61

P407

Q35095489-AF1AC81C-F646-4717-A7B2-4CED354EB58B

P433

Q35095489-9BD49F0A-3BF8-4B72-9117-D3DAF1F0A084

P478

Q35095489-783C728F-78BD-4459-A97E-044980930C9D

P50

Q35095489-35C6ACB9-9C43-4C28-8901-9D0390232156

Q35095489-88517313-BB60-4045-9A55-0C4DC1745925

P577

Q35095489-8F09F7F0-6ADC-4EC4-9E8F-582C7AB9C863

P5875

Q35095489-138018CF-4C1B-4028-8100-0FD9D54F2E43

P698

Q35095489-12A96F3E-5540-44F7-8959-75CE9D4B4B88

P921

Q35095489-458B6002-88CF-4FEA-BA24-5EA2C779FE31

Q35095489-C56AE26D-EEA1-47FB-AC92-0C77BD14257F

P932

Q35095489-EF7AB90E-3B7A-45E6-8D33-E0F8A4F6E49F

P356

SCIENCE.1188280

P1433

P1476

Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity.

@en

P2093

Akihiko Shimono

http://www.w3.org/2001/XMLSchema#string

Akiko Higuchi

http://www.w3.org/2001/XMLSchema#string

Koji Ohashi

http://www.w3.org/2001/XMLSchema#string

Noriyuki Ouchi

http://www.w3.org/2001/XMLSchema#string

Rei Shibata

http://www.w3.org/2001/XMLSchema#string

Yuichi Akasaki

http://www.w3.org/2001/XMLSchema#string

Yuichi Oshima

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of adipogenesis by Wnt signaling

Sfrp5 coordinates foregut specification and morphogenesis by antagonizing both canonical and noncanonical Wnt11 signaling

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

Inflammation and metabolic disorders

Obesity is associated with macrophage accumulation in adipose tissue

JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity

Secreted antagonists of the Wnt signalling pathway

A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling

A central role for JNK in obesity and insulin resistance

Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans

P304

454-457

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCIENCE.1188280

http://www.w3.org/2001/XMLSchema#string

P407

P433

5990

http://www.w3.org/2001/XMLSchema#string

P478

329

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-06-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44683384

http://www.w3.org/2001/XMLSchema#string

P698

20558665

http://www.w3.org/2001/XMLSchema#string

P921

P932

3132938

http://www.w3.org/2001/XMLSchema#string